Hydralazine Hydrochloride
- Product NDC
- 70934-764
- 11-digit product format
- 709340764
- Labeler code
- 70934
- Product ID
- 70934-764_a97a6682-49eb-477c-e053-2a95a90a0bec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA040901
- Marketing category
- ANDA
- Marketing start
- 2020-06-08
- Marketing end
- 0000-00-00
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-764-96 | 70934076496 | 180 TABLET in 1 BOTTLE, PLASTIC (70934-764-96) | 180 tablet | 2020-06-08 | 0000-00-00 | No | No | Current |